Ticker Symbol: CRJTF

Crossject

Exchange: US OTC Country: FR Currency: USD Asset Type: Common Stock

Company Profile

Crossject SA manufactures and markets needle-free injection system. It develops and produces generic drugs such as methotrexate, epinephrin, and sumatriptan. The company distributes its products under the Zeneo brand. Crossject was founded by Patrick Alexandre and Xavière Castano on August 8, 2001 and is headquartered in Dijon, France.

Sector: Health Technology

Industry: Medical Specialties

Standard Industrial Classification Code (SIC code): 3841

Address: 6, rue Pauline Kergomard

Website: http://www.crossject.com

CEO: Patrick Alexandre

Tags:

Medical Specialties
Health Technology

Pricing

Last Updated: December 31, 1969 07:00 PM EST

Previous Close: -

Change: - ( 0.00%)

Days Range: $3.25 - $3.96

Beta: -

52wk. High: -

52wk. Low: -

Ytd. Change 0.00%

50 Day Moving Average: -

200 Day Moving Average: -

Shares Outstanding: 33816689

Valuation

Market Cap: 11.0B

PE Ratio: -

EPS (TTM): 0

Dividends

Dividend Per Share (TTM): -

Dividend Yield (TTM): 0.00%

Ex-Dividend Date: N/A